Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The document concludes that modern ocular cosmetics enhance beauty and eyelash health, with safe practices and regulations being important.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Finasteride causes reduced tear flow and severe eye inflammation.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Key genes linked to hair growth and cancer were identified in hairless mice.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Methamphetamine affects gene expression in rat whisker follicles, with key genes linked to addiction.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Iron deficiency might contribute to hair loss in women.